Discover
AYTU
Aytu BioPharma, Inc.
2.02
2 x 1.54
2 x 2.75
bid
ask
-
0.02
1.22%
2 @ 05:22 PM
1.99 -0.04 (1.91%)
| Ytd | -22.12% | |
| 1y | -19.32% |
2.02
day range
2.07
1.94
52 week range
2.90
| Open | 2.04 | Prev Close | 2.05 | Low | 2.02 | High | 2.07 | Mkt Cap | 22.01M |
| Vol | 10.53K | Avg Vol | 34.22K | EPS | -1.14 | P/E | N/A | Forward P/E | 3.57 |
| Beta | -1.40 | Short Ratio | 10.45 | Inst. Own | 34.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 2.21 | 200-d Avg | 2.37 | 1yr Est | 8.00 |
| Income Statement | |||
| Total Revenue | 16.11M | ||
| Revenues (USD) | 16.11M | ||
| Cost of Revenue | 5.70M | ||
| Gross Profit | 10.41M | ||
| Operating Expenses | 11.19M | ||
| Selling, General and Administrative Expense | 10.43M | ||
| Operating Income | -777.00K | ||
| Interest Expense | 383.00K | ||
| Income Tax Expense | 11.00K | ||
| Net Income | -15.00K | ||
| Net Income Common Stock | -15.00K | ||
| Net Income Common Stock (USD) | -15.00K | ||
| Consolidated Income | -15.00K | ||
| Earnings per Basic Share | 0.26 | ||
| Earnings per Basic Share (USD) | 0.26 | ||
| Earnings per Diluted Share | 0.26 | ||
| Earning Before Interest & Taxes (EBIT) | 379.00K | ||
| Earning Before Interest & Taxes (USD) | 379.00K | ||
| Weighted Average Shares | 12.32M | ||
| Weighted Average Shares Diluted | 12.32M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.31M | ||
| Cash and Equivalents (USD) | 26.31M | ||
| Trade and Non-Trade Receivables | 22.78M | ||
| Current Assets | 61.76M | ||
| Property, Plant & Equipment Net | 1.24M | ||
| Total Assets | 105.01M | ||
| Debt Current | 7.93M | ||
| Total Debt | 17.03M | ||
| Current Liabilities | 54.66M | ||
| Debt Non-Current | 9.10M | ||
| Total Liabilities | 69.73M | ||
| Accumulated Retained Earnings (Deficit) | -347.79M | ||
| Shareholders Equity | 35.27M | ||
| Shareholders Equity (USD) | 35.27M | ||
| Assets Non-Current | 43.25M | ||
| Total Debt (USD) | 17.03M | ||
| Goodwill and Intangible Assets | 41.40M | ||
| Inventory | 6.86M | ||
| Liabilities Non-Current | 15.07M | ||
| Trade and Non-Trade Payables | 11.28M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.12M | ||
| Net Cash Flow from Financing | -4.80M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -407.00K | ||
| Capital Expenditure | -12.00K | ||
| Issuance (Repayment) of Debt Securities | -4.80M | ||
| Net Cash Flow from Investing | -12.00K | ||
| Net Cash Flow from Operations | 4.41M | ||
| Share Based Compensation | 146.00K | ||